JP2010520176A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520176A5
JP2010520176A5 JP2009551218A JP2009551218A JP2010520176A5 JP 2010520176 A5 JP2010520176 A5 JP 2010520176A5 JP 2009551218 A JP2009551218 A JP 2009551218A JP 2009551218 A JP2009551218 A JP 2009551218A JP 2010520176 A5 JP2010520176 A5 JP 2010520176A5
Authority
JP
Japan
Prior art keywords
phenyl
dihydroxy
isopropyl
isoxazole
morpholin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009551218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520176A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/052443 external-priority patent/WO2008104595A1/en
Publication of JP2010520176A publication Critical patent/JP2010520176A/ja
Publication of JP2010520176A5 publication Critical patent/JP2010520176A5/ja
Pending legal-status Critical Current

Links

JP2009551218A 2007-03-01 2008-02-28 ５−（２，４−ジヒドロキシ−５−イソプロピル−フェニル）−４−（４−モルホリン−４−イルメチル−フェニル）−イソオキサゾール−３−カルボン酸エチルアミドの酸付加塩、水和物および多形、ならびにこれらの形態を含む製剤 Pending JP2010520176A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103346 2007-03-01
PCT/EP2008/052443 WO2008104595A1 (en) 2007-03-01 2008-02-28 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

Publications (2)

Publication Number Publication Date
JP2010520176A JP2010520176A (ja) 2010-06-10
JP2010520176A5 true JP2010520176A5 (enExample) 2011-04-07

Family

ID=38134307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551218A Pending JP2010520176A (ja) 2007-03-01 2008-02-28 ５−（２，４−ジヒドロキシ−５−イソプロピル−フェニル）−４−（４−モルホリン−４−イルメチル−フェニル）−イソオキサゾール−３−カルボン酸エチルアミドの酸付加塩、水和物および多形、ならびにこれらの形態を含む製剤

Country Status (40)

Country Link
US (3) US8163747B2 (enExample)
EP (2) EP2545921A3 (enExample)
JP (1) JP2010520176A (enExample)
KR (1) KR20090122218A (enExample)
CN (2) CN101636162A (enExample)
AR (1) AR065519A1 (enExample)
AT (1) ATE552836T1 (enExample)
AU (1) AU2008220800B2 (enExample)
BR (1) BRPI0807992A2 (enExample)
CA (1) CA2678043A1 (enExample)
CL (1) CL2008000618A1 (enExample)
CO (1) CO6210828A2 (enExample)
CR (1) CR10989A (enExample)
CY (1) CY1113805T1 (enExample)
DK (1) DK2131845T3 (enExample)
DO (1) DOP2009000209A (enExample)
EA (1) EA017075B1 (enExample)
EC (1) ECSP099602A (enExample)
ES (1) ES2384906T3 (enExample)
GE (1) GEP20115309B (enExample)
GT (1) GT200900236A (enExample)
HR (1) HRP20120535T1 (enExample)
IL (1) IL200401A0 (enExample)
MA (1) MA31204B1 (enExample)
MX (1) MX2009009233A (enExample)
NI (1) NI200900161A (enExample)
NZ (1) NZ578854A (enExample)
PA (1) PA8771101A1 (enExample)
PE (1) PE20090166A1 (enExample)
PL (1) PL2131845T3 (enExample)
PT (1) PT2131845E (enExample)
RS (1) RS52351B (enExample)
SI (1) SI2131845T1 (enExample)
SM (1) SMAP200900080A (enExample)
TN (1) TN2009000357A1 (enExample)
TW (1) TW200844102A (enExample)
UA (1) UA101950C2 (enExample)
UY (1) UY30943A1 (enExample)
WO (1) WO2008104595A1 (enExample)
ZA (1) ZA200905417B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200922595A (en) * 2007-10-12 2009-06-01 Novartis Ag Organic compounds
TWI450898B (zh) * 2008-07-04 2014-09-01 Sigma Tau Res Switzerland Sa 具有抗腫瘤活性之芳基異唑化合物
WO2010060854A1 (en) 2008-11-25 2010-06-03 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
BR112012017994B8 (pt) * 2010-01-21 2020-12-08 Aprea Ab composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio
JP2013519727A (ja) * 2010-02-17 2013-05-30 イルドン ファーム シーオー．，エルティーディー． 新規の５員複素環誘導体及びその製造方法
KR20120031854A (ko) 2010-09-27 2012-04-04 한국전자통신연구원 시간 및 주파수 특징을 이용하는 음악 음원 분리 장치 및 방법
WO2013015661A2 (en) * 2011-07-28 2013-01-31 Ildong Pharm Co.,Ltd. Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101166749B1 (ko) * 2003-02-11 2012-07-27 베르날리스(캠브리지)리미티드 열쇼크 단백질 저해제로서의 이소옥사졸 화합물
US20060070405A1 (en) * 2004-10-06 2006-04-06 Anheuser-Busch, Inc. Method for the production of amber glass with reduced sulfur-containing emissions
CA2677651A1 (en) 2007-02-15 2008-08-21 Novartis Ag Combinations of therapeutic agents for treating cancer
WO2010069458A1 (de) 2008-12-17 2010-06-24 Merck Patent Gmbh Hexahalochromat(lll)-komplexe

Similar Documents

Publication Publication Date Title
JP2010520176A5 (enExample)
JP2008538741A (ja) 鬱病の治療用及び／又は予防用の医薬組成物
JP5907975B2 (ja) 運動障害の治療のためのセロトニン受容体アゴニストの組み合わせ
EP2389362A1 (en) Phenylcyclopropylamine derivatives and their medical use
JP2010515715A5 (enExample)
JP2017528507A5 (enExample)
JP2016503009A5 (enExample)
JP2009533356A5 (enExample)
US20240277673A1 (en) Methods of treating behavior alterations
EP2455080A1 (en) S1P1 receptor agonists for use in the treatment of multiple sclerosis
JP2007533687A5 (enExample)
RU2006140964A (ru) Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин
ES2928684T3 (es) Agente terapéutico para la fibrosis
JP2016503010A5 (enExample)
RU2011146032A (ru) Соединения-агонисты рецептора 5-ht4 для лечения расстройств познавательной способности
JP2023143940A5 (enExample)
US11191748B2 (en) Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
JP2014513705A (ja) 進行性固形腫瘍の治療方法
JP2009532438A5 (enExample)
JP2009513604A5 (enExample)
TN2009000357A1 (en) ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5¬(2,4-DIHYDROXY-5- ISOPROPYL-PHENYL)- 4- (4-MORPHOLIN -4¬YLMETHYL-PHENYL) - ISOXAZOLE-3-CARBOXYLlC ACID ETHYLAMIDE AND FORMULATIONS COMPRISING THESE FORMS
JP2021522246A (ja) 癌治療のための併用
CN100506224C (zh) 包含选择性环加氧酶-2抑制剂的组合
BR112013000164B1 (pt) Agente terapêutico ou agente profilático
JP2020503318A5 (enExample)